Full-Spectrum Generative Lead Discovery (FSGLD) — DRUG-GAN for Drug Discovery
CONCEPTThe Full-Spectrum Generative Lead Discovery (FSGLD) pipeline integrates deep learning-driven generative modeling with molecular docking, dynamics simulations, ligand-residue interaction profiling, MM-PBSA calculations, thermodynamic integration, and experimental validation. The core multiscale DRUG-GAN models enable guided discovery of drug-like, target-specific compounds by bridging theoretical design with practical application. This approach represents a maturation of AI-driven drug discovery beyond sequence generation, incorporating physics-based validation, binding affinity prediction, and pharmacophore optimization. The pipeline's integration of experimental validation loops addresses a critical gap in AI drug discovery: the need to validate computational predictions in wet-lab settings before clinical translation. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.